The membranes' role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation

Antiviral Research
Ana Salomé Veiga, Miguel A R B Castanho

Abstract

2F5, a monoclonal antibody that neutralizes HIV-1 primary isolates, recognizes an epitope in the membrane proximal region of the glycoprotein gp41 ectodomain. It is believed that binding to the viral membrane is a step in the antibody mode of action, as usual in ligand membrane receptor interactions. We investigated the interaction of 2F5 with membrane model systems, namely large unilamellar vesicles, by means of fluorescence techniques. There were no significant interactions of 2F5 with model viral membranes or with model target cell membranes. Thus, the usual three-step 'membrane catalysis' method is not followed by 2F5 in its mode of action.

References

Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D F Sargent, R Schwyzer
Jun 13, 1986·Biochimica Et Biophysica Acta·L D MayerP R Cullis
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R C AloiaF C Jensen
Jun 18, 1998·Cell·D C Chan, P S Kim
Sep 6, 2000·Trends in Biochemical Sciences·J A Killian, G von Heijne
Mar 9, 2002·Journal of Virology·Christoph GrundnerRichard Wyatt
Feb 26, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Louise A Cooley, Sharon R Lewin
Nov 13, 2004·Journal of the American Chemical Society·A Salomé VeigaMiguel A R B Castanho
Oct 12, 2005·European Biophysics Journal : EBJ·Miguel A R B Castanho, Miguel X Fernandes
Nov 18, 2005·Biochimica Et Biophysica Acta·Salomé VeigaMiguel A R B Castanho

❮ Previous
Next ❯

Citations

Nov 13, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Xiaoli ZhangHong Shang
Mar 14, 2009·Chembiochem : a European Journal of Chemical Biology·Ana S VeigaMarie Isabel Aguilar

❮ Previous
Next ❯

Related Concepts

Related Feeds